Repository navigation
SYNAPTIK v0.7.0 (Alpha): Autonomous N-of-1 Rare Disease & Translational Pipeline
SYNAPTIK v0.7.0 (Alpha): Autonomous N-of-1 Rare Disease & Translational Pipeline
SYNAPTIK v0.7.0 unifies patient genomic discovery and regulatory-ready therapeutic translation into an autonomous closed-loop platform.
Highlights
- Autonomous N-of-1 Rare Disease Pipeline (\synaptik nof1):
- Splicing mechanism resolution for cryptic exon targets (STMN2, UNC13A, SMN2, ELP1, COL6A1, ATXN2, TARDBP).
- In vivo human post-mortem single-cell concordance against human motor cortex snRNA-seq atlases.
- In silico therapeutic ASO engineering with thermodynamic and specificity validation.
- Causal genomic counterfactual simulation predicting network transcriptomic recovery.
- Longitudinal fluid biomarker trajectory modeling (Plasma NfL) and patient clinical stratification.
- Preclinical study design protocol generation with SHA-256 pre-registration fingerprint and 96-well randomized complete block layout.
- Production of audit-ready, 7-page Markdown IND-enabling dossiers (--dossier ).
- Interactive Laboratory Web Dashboard & REST API Suite (\synaptik ui):
- Web interface with dedicated N-of-1 Pipeline execution and citation export tabs.
- REST API endpoints: /api/nof1, /api/aso, /api/translate, /api/simulate, /api/biomarker, /api/protocol, /api/cite.
- Author Recognition & Citation Framework (\synaptik cite):
- Lead Author: Francesco Nobile (ORCID: 0009-0001-9477-3332), Center for Genomic Medicine, Massachusetts General Hospital / Harvard Medical School & University of Pavia.
- CI Test Suite: 406 passing checks across 10 test suites on Python 3.10, 3.11, and 3.12.